Entera Bio Ltd. (ENTX)
2.84
-0.17
(-5.65%)
USD |
NASDAQ |
Sep 09, 16:00
2.84
0.00 (0.00%)
After-Hours: 17:10
Entera Bio Shareholders Equity (Quarterly) : 7.266M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.266M |
| March 31, 2026 | 10.69M |
| December 31, 2025 | 13.10M |
| September 30, 2025 | 15.23M |
| June 30, 2025 | 17.26M |
| March 31, 2025 | 19.38M |
| December 31, 2024 | 8.08M |
| September 30, 2024 | 6.452M |
| June 30, 2024 | 8.532M |
| March 31, 2024 | 8.863M |
| December 31, 2023 | 10.39M |
| September 30, 2023 | 6.236M |
| June 30, 2023 | 8.232M |
| March 31, 2023 | 10.08M |
| December 31, 2022 | 11.75M |
| September 30, 2022 | 14.31M |
| June 30, 2022 | 17.27M |
| March 31, 2022 | 19.74M |
| December 31, 2021 | 22.56M |
| Date | Value |
|---|---|
| September 30, 2021 | 25.98M |
| June 30, 2021 | 25.32M |
| March 31, 2021 | 7.613M |
| December 31, 2020 | 7.51M |
| September 30, 2020 | 5.74M |
| June 30, 2020 | 7.229M |
| March 31, 2020 | 10.02M |
| December 31, 2019 | 11.92M |
| September 30, 2019 | 4.038M |
| June 30, 2019 | 6.468M |
| March 31, 2019 | 7.662M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -31.56M |
| September 30, 2017 | -28.64M |
| June 30, 2017 | -26.76M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 13.77M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 269.56M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 12.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.48M |
| Total Liabilities (Quarterly) | 12.21M |
| Debt to Equity Ratio | 0.0585 |
| Current Ratio | 8.981 |
| Net Debt Paydown Yield | -0.05% |